510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K111728Substantially Equivalent

Emv3 Self Monitoring Blood Glucose System, Emv3 Pro Self Monitoring Blood Glucose System

Eps Bio Technology Corp., Hsinchu, TW / Special, Substantially Equivalent
FDA source (opens on fda.gov)

K111728 is the FDA 510(k) clearance record for EMV3 SELF MONITORING BLOOD GLUCOSE SYSTEM, EMV3 PRO SELF MONITORING BLOOD GLUCOSE SYSTEM, a class II device, cleared for Eps Bio Technology Corp. on under FDA product code CGA (Glucose Oxidase, Glucose). FDA records list 24 510(k) clearances for Eps Bio Technology Corp., from to . As of , FDA records show no recalls naming K111728.

Clearance record

Decision date
Received
(88 days to decision)
Product code
CGA Glucose Oxidase, Glucose
Regulation
21 CFR 862.1345
Device class
Class II
Review panel
Clinical Chemistry
Applicant
Eps Bio Technology Corp. # 8 R&D Rd.Iii, Hsinchu Science Park, Hsinchu, TW
510(k) summary
Statement
Third party review
No

Clearances, product code CGA

Trailing 12 months
1 clearance under product code CGA in the twelve months to October 2026, May 2026 the highest month at 1.
Show the numbers
Monthly 510(k) clearances under FDA product code CGA, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20261
June 20260
July 20260
August 20260
September 20260
October 20260